By employing three strains of cultivable human rotaviruses with different serotype specificity as immunizing antigens, we prepared 11 hybridomas which secreted neutralizing monoclonal antibodies against human rotaviruses. In neutralization tests with four strains of serotype 1, and three each of serotypes 2 and 3, the monoclonal antibodies showed different reactivity patterns: seven monoclonal antibodies reacted specifically with all strains of either serotype 1, 2 or 3 human rotavirus, but two showed strain-specific reactions: the remaining two were commonly reactive to various human rotavirus strains from each serotype but not to two non-human rotaviruses. By immunoprecipitation analysis, it was found that four serotype 2-specific and two commonly reactive antibodies were directed to VP3 (82000 mol. wt. protein) on the outer shell of the virus particles.
INTRODUCTION
Since Zissis & Lambert (1978) postulated the existence of serologically different human rotaviruses (HRVs), antigenic diversity of HRVs has been revealed by various serological methods such as complement fixation, enzyme-linked immunosorbent assay (ELISA), immune electron microscopy (IEM), and neutralization (Flewett et al., 1978 ; Yolken et al., 1978 ; Zissis & Lambert, 1980) . Later, Kapikian et al. (1981 ) found that the antigen recognized by their ELISA or immune adherence haemagglutination (IAHA) system and the antigen defined by neutralization were different from each other. Since then, according to the proposal by Kapikian et al. (1981) , the terms 'subgroup' and 'serotype' antigens have been employed for the IAHA (or ELISA) and neutralization antigens, respectively. So far, at least two subgroups and four serotypes have been demonstrated in HRV (for review, see Estes et al., 1983) . Gene coding assignments (Smith et al., 1980; McCrae & McCorquodale, 1982) and analysis of reassortant viruses Greenberg et al., 1983a) have shown that subgroup specificity is associated with VP6 (42000 mol. wt. protein: 42K protein), a major component of the inner capsids, which is coded for by RNA segment 6, while serotype specificity is defined by VP7 (34K to 38K glycoprotein) on the outer capsids and encoded by RNA segment 8 or 9.
For further antigenic characterization of H RV, the use of monoclonal antibodies was thought to be greatly valuable as has been demonstrated with other viruses (Stone et al., 1979; Yewdell & Gerhard, 1981 : Appleton & Letchworth, 1983 . However, the difficulty in cultivation of HRV has hampered the introduction of hybridoma technology: recently, however, successful direct propagation of fastidious HRV from stool specimens has made it possible to obtain numerous cultivable H RV strains (Sato et al., 1981 ; U rasawa et al., 1981) . In our previous studies, using cultivable HRV strains with different subgroup and serotype specificities, we prepared subgroup-specific and commonly reactive non-neutralizing monoclonal antibodies which were directed to VP2 or VP6 (Taniguchi et al., 1984, and unpublished results) . We could not obtain, however, any hybridomas producing neutralizing antibodies. There were two possible reasons for this : one might be the procedure by which purified HRV used as immunizing antigens were prepared, and the other the screening assay of hybridoma culture fluid. To obtain neutralizing 0000-6323©1985 SGM monoclonal antibodies against HRV efficiently, we took these two points into consideration in the present study. The present paper deals with the method for obtaining anti-HRV neutralizing monoclonal antibodies, their neutralizing reactivity patterns and their polypeptide specificities.
METHODS

Virus.
The following cultivable HRV strains were employed in this study: (i) KU, K8, S12 and Wa strains (subgroup II, serotype 1), (ii) $2, DS-I and HN-126 strains (subgroup I, serotype 2), and (iii) YO, $3 and M-28 strains (subgroup II, serotype 3). KU, K8, S12, $2, YO and $3 strains were isolated in our laboratory , while M-28 strain was supplied by R. Shirachi (Miyagi Prefectural Institute of Health, Japan) and Wa, DS-1 and H N-126 strains by R. G. Wyatt (National Institutes of Health, Bethesda, Md., U.S.A.). Simian rotavirus (SAIl) and calf rotavirus (Lincoln strain) were used as reference animal rotaviruses. Serological relationships among the above-mentioned rotavirus strains have already been described Urasawa et al., 1984) . All the viruses employed in this study were cloned three times by a plaque formation technique . Unless otherwise stated, the viruses were pretreated with 10 pg/ml of acetylated trypsin (Type V-S from bovine pancreas; Sigma), propagated in MA-104 cells in the presence of trypsin (1 ~tg/ml), and harvested 1 to 3 days after infection.
Virus purification. Monolayer cultures of MA-104 cells were infected with HRV pretreated with trypsin at multiplicities of 2 to 5 p.f.u./cell. Virus was grown for 1 to 2 days in Eagle's minimum essential medium (MEM) with trypsin (/)-5 ~tg/ml) or without. Tbe infected cells were subjected to two cycles of freezing and thawing and the culture fluids were centrifuged to remove cell debris. Supernatants were centrifuged at lO0000g for 3 h and pellets were suspended in phosphate-buffered saline containing 0-5 mM-MgCI, and 1 mM-CaC12 (PBS). After fluorocarbon treatment, virus solution was concentrated by centrifugation at 100000 g for 2 h. Virus pellets were suspended in 1 ml of PBS and layered on 3.5 ml of a discontinuous (1.0, 1.1, 1.2, 1.3, 1.4, 1.5 and 1.6 g/ml) Metrizamide (Aldrich) gradient and centrifuged at 100 000 g for 18 h. The virus band was collected and dialysed against PBS.
Counting of~,irus particles. Virus samples were mixed with an equal volume of latex bead suspension (87 nm diam. Dow Chemical, U.S.A.) containing 2.87 x 10 lo particles/ml. The mixture was dropped onto a 400-mesh carbon-collodion-coated grid and stained with 3°,g uranyl acetate. Double -shelled (DS) and single-shelled (SS) particles of HRV and latex particles were counted in random fields of the grid by electron microscopy (EM). The concentration of virus particles was calculated as follows: virus particles/ml ~ (virus particles counted/latex particles counted) x 2.87 × 10 l°.
IEM. Purified HRV particles (KU, $2 or YO strain) were mixed with each hybridoma culture fluid (200 ~1) and incu bated for 1 h at room temperature. The mixture was then processed for EM as described previously (Taniguchi et al., 1984) , except that 3°0 uranyl acetate was employed as a staining solution.
Preparation o~ hybridomas. Purified $2, KU and YO strains were used as immunizing antigens. P3-X63-Ag8. 653 mouse myeloma cells were fused with spleen cells from immunized mice as described previously (Taniguchi et al., 1983 ). Hybridomas producing anti-H RV neutralizing antibodies were identified by assaying the culture fluid with a fluorescent focus neutralization test as described below. Hybridomas secreting high-titred anti-HRV neutralizing antibodies were selected and cloned twice by limiting dilution. The isotypes of the immunoglobulins produced by the hybridomas were determined by Ouchterlony double-immunodiffusion tests using rabbit antisera to mouse lgG, IgM, IgG1, IgG2a, IgG2b and lgG3 (Miles Yeda, Rehovot, Israel) . To obtain ascitic fluid, 107 hybridoma cells were inoculated intraperitoneally into Pristane-primed BALB/c mice.
Fluorescent&cus (FF) neutralization. For screening the hybridomas that produced neutralizing antibodies and for determination of neutralizing titres, fluorescent focus neutralization tests were employed (Urasawa et al., 1981 ) . A 1 : 5 dilution (for screening) or twofold serial dilutions (for determination of neutralizing antibody titres) of each hybridoma culture fluid was reacted with virus suspension containing either 500 to 1000 fluorescent focusforming units (f.f.u.)/0.025 ml (for screening) or 150 to 200 f.f.u./0.025 ml (for neutralizing antibody titration) for 1 h. At 18 to 24 h post-infection, the infected cells were fixed with methanol and reacted with a 1 : 15 dilution of anti-HRV rabbit serum (a mixture of antisera to KU, $2 and YO strains) for 1 h. After the additional 1 h reaction with a 1:15 dilution of fluorescein isothiocyanate-conjugated anti-rabbit IgG goat serum (MBL, Japan), the number of FF was counted by vertically illuminated fluorescence microscopy (type BH-RFL, Olympus, Japan). For screening the hybridoma culture fluid, wells that showed about 50 or fewer FF were considered positive for anti-H RV neutralizing antibody. In neutralizing antibody titrations, the reciprocal of the highest serum dilution that reduced the FF more than 600,o of that in the control wells was taken as the neutralizing titre.
Plaque neutralization test. The neutralizing titre of some of the ascitic fluids was measured by the 60°o plaque reduction method as described previously .
Preparation o/labelled viral anti~,en. Confluent MA-104 cells in 70 mm Petri dishes were infected at multiplicities of 5 to I 0 with K U, $2 and YO strains of H RV and SA 11 virus pretreated with trypsin (10 ~g/ml). Virus adsorption was for 1 h, after which the inoculum was replaced with MEM containing 5 ~tg/ml of actinomycin D (MEM AD).
At 8 h (for SA 11 virus) or 12 h (for HRV) after infection, monolayer cells were washed and incubated for l h with methionine-free MEM AD. Monolayer cells were then incubated for 1 h with MEM AD containing 25 to 50 pCi of[35S]methionine (800 to 1200 Ci/mmol; Amersham) per Petri dish. Again cells were washed and incubated for 1 h with MEM-AD. Then, culture supernatants were removed and monolayers dissolved in 1 ml of lysis buffer (0.8 M-KCI, 10 mM-Tris HC1, 1 mM-phenylmethylsulphonyl fluoride. 1°~, Triton X-100, pH 7.8), followed by the addition of 3 ml of the same buffer without K C1 (Lee et al., 1981 ) . After the lysates had been homogenized with a Teflon homogenizer (10 strokes), the homogenates were clarified by centrifugation at 100000 g for 30 min and stored before use at -80 °C.
Immunoprecipitation. To eliminate non-specific reactions, 20 pl of viral lysate was incubated with 100 pl culture fluid of P3-X63-Ag8.653 cells for 1 h, followed by incubation with 50 pl of a 10°-;; suspension of Staphylococcus aureus bearing Protein A for an additional 15 rain. After the mixture was centrifuged, the supernatant was used for immunoprecipitation analysis. To the pre-absorbed viral lysate, 100 pl of culture fluid from the hybridoma was added and incubated at room temperature for I h. The m xture was incubated with 60 lal ofa 10°~o suspension orS.
aureus cells at room temperature for 15 min, and centrifuged. The pellet was washed twice with washing buffer (2.5 M-KCI, 150 mM-NaC1, 50 mM-Tris-HCl, 0.5 ~; Nonidet P°40, pH 8.0) and twice with the same buffer without KCI. The immunoprecipitated protein was eluted by mixing the pellet with 50 lal of solubilizing buffer (50 mM-Tris-HCI. 270 SDS, 5°~ 2-mercaptoethanol, pH 6.8) and boiling for 4 min. Samples were analysed by SDS polyacrylamide gel electrophoresis in 12.5°.o slab gels. Autoradiography of the dried gels was enhanced by fluorography using salicylic acid (Chamberlain, 1979) . Molecular weight standards used were l"~C-labelled myosin (200K), phosphorylase b (92.5K), bovine serum albumin (69K), ovalbumin (46K), carbonic anhydrase (30K), and lysozyme (14.3K), supplied by Amersham.
RESULTS
Preparation of neutralizing monoclonal antibodies against HR V
Neutralizing antigens of rotaviruses are thought to reside on the outer layer of the DS particles. Accordingly, in order to prepare hybridomas secreting neutralizing antibodies efficiently, it was considered necessary to immunize mice with virus preparations containing high proportions of DS particles. Since we have noticed that the purified preparation of HRV grown in the presence of trypsin (1 ~g/ml) in our previous study (Taniguchi et al., 1984) had a small proportion of DS particles, we first examined the effect of trypsin (0, 0.5 or 2 ~tg/ml) in the maintenance medium on the stability of HRV particles. As shown in Table 1 , the highest ratio of DS to SS particles was found in the HRV grown without trypsin although the total number of HRV particles was larger when propagated in the presence of trypsin. Furthermore, in isopycnic banding in CsC1 of concentrated HRV, a remarkable breakdown of DS particles to SS particles was observed. In contrast, the purification of HRV by centrifugation through the Metrizamide gradient preserved the integrity of the DS HRV particles (data not shown). Based on these results, we prepared the purified HRV for immunizing mice by propagating HRV pretreated with trypsin in cells using maintenance medium without trypsin (or in some cases with 0.5 ~tg/ml of trypsin), and purifying the virus by Metrizamide gradient centrifugation.
Concerning the screening assay, the selection of monoclonal antibodies with high binding activity in radioimmunoassay in our previous study (Taniguchi et al., 1984) might have resulted in the preferential selection of non-neutralizing antibodies. Therefore, in the present study, the fluorescent focus neutralization test using microplates was chosen as the screening procedure. Particle number/ml (~tg/ml) ¢ ~ in maintenance medium DS particles SS particles Total 2"0 6"1 × 10 t° 3"9 × 10 tt 4"5 × 10 l~ 0"5 1"2 z l0 t~ 6"3 × 10 tt 7"5 × 10 tl 0 8"4 × 10 ~° 5'0 × 10 ' 8"9 × 101° * After K8 strain-infected cultures were harvested at 48 h post-infection and frozen and thawed three times, the samples were partially purified and concentrated by polyethylene glycol precipitation and ultracentrifugation on 452,0 sucrose. Particle number was counted by EM observation using a latex particle suspension of known concentration as described in Methods. Another experiment using a different preparation of virus was carried out and similar results were obtained.
• N . Fig. 1 . IEM of reaction between $2-2F2 antibody and $2 strain of HRV. The antibodies bound exclusively to DS particles (indicated by arrowheads). Bar marker represents 100 nm.
Using these modified procedures, we obtained 11 hybridomas secreting neutralizing monoclonal antibodies. Two (KU-3C7 and KU-4D7), seven ($2-2F2, $2-2F3, $2-2G10, $2-2H11, $2-3H8, $2-3E 12 and $2-4E9), and two (YO-2C2 and YO-3H7) hybridomas were derived from fusing mouse myeloma cells with spleen cells obtained from mice immunized with KU (serotype 1), $2 (serotype 2) and YO (serotype 3) strains, respectively. $2-2G10, $2-4E9, YO-2C2 and YO-3H7 hybridomas secreted IgG2a, and $2-2F2, $2-2F3 and $2-3H8 hybridomas produced IgG2b. The isotype of $2-2Hll, $2-3E12 and KU-3C7 antibodies was IgG3. Hybridoma KU-4D7 also secreted IgG, but it did not react with any of the antisera to IgG1, IgG2a, IgG2b or IgG3. In IEM, the neutralizing antibodies thus obtained were found to agglutinate exclusively double-shelled particles (Fig. 1) , indicating that they are directed to the outer capsid protein.
Reactivity of monoclonal antibodies to various rotavirus strains
In fluorescent focus neutralization tests (Table 2) , KU-3C7 antibody neutralized the infectivities of all four serotype 1 HRV strains but none of the serotype 2 and 3 HRV strains. $2-2F2, $2-2F3, $2-2G10, $2-3H8 and $2-4E9 antibodies showed only serotype 2-specific reactivity. Similarly, YO-3H7 antibody neutralized serotype 3 HRV strains as well as SA11 virus which has been recently shown to be related serologically to serotype 3 HRV (Wyatt et al., 1982) . $2-2H11 and $2-3E12 antibodies were specific for the homologous $2 strain. The remaining two antibodies, KU-4D7 and YO-2C2, reacted commonly with all but one of the HRV strains from the three serotypes, but did not neutralize two representative animal rotaviruses (SA11 virus and Lincoln strain). The reactivities of ascitic fluids from nine representative hybridomas were also examined by plaque neutralization tests (Table 2 ). Their reactivity patterns were similar and their neutralizing titres were 2-5 to 640 times higher than the corresponding culture fluids. Thus, the reactivity patterns of the anti-HRV neutralizing monoclonal antibodies obtained in this study were divided into three categories: strain-specific, serotype-specific and commonly reactive patterns. 
Reactivity patterns of neutralizing monoclonal antibodies against HR V
Neutralizing titre against 
Immunoprecipitation analysis
The protein profiles of three HRV strains (KU, $2 and YO) and SA 11 virus were compared by SDS polyacrylamide gel electrophoresis (Fig. 2) . Even when cells were infected with these strains at high multiplicities and in the presence of actinomycin D, cellular protein synthesis was not completely inhibited, especially in the cells infected with the YO strain. Nevertheless, by referring to the SA 11 polypeptides extensively characterized previously (for review, see Estes et al., 1983) , we could identify the viral polypeptides of HRV strains, except that the protein band of HRV corresponding to VP7 of SAll virus was not clearly identified under the conditions given in the present study. Although overall protein patterns were similar among the four strains, slight differences in the molecular weights of some viral polypeptides were observed.
In immunoprecipitation analysis using the p~S]methionine-labelled viral lysate, four serotype 2-specific antibodies ($2-2F2, $2-2F3, $2-3H8 and $2-4E9) precipitated VP3 of $2 strain, as shown in Fig. 3 . Commonly reactive K U-4D7 and YO-2C2 antibodies precipitated VP3 of both KU and YO strains (Fig. 3 and 4) , but showed little reactivity to a viral lysate of the $2 strain. The remaining five antibodies failed to immunoprecipitate any of the virus-specific polypeptides of HRV strains. Four non-neutralizing antibodies employed as references immunoprecipitated VP6 or VP2 (Fig. 4 and 5 ) as described previously (Taniguchi et al., 1984, and unpublished results) : $2-37 antibody precipitated VP6 of $2 strain, YO-5 and YO-156 antibodies VP6 of KU and YO strains, and YO-60 antibody VP2 of KU and YO strains.
DISCUSSION
Serological relationships among various HRV strains isolated in different laboratories have been elucidated by recent comparative studies by plaque neutralization tests using polyclonal antisera Urasawa et al., 1984) . As a result, four representative serotypes were discriminated: KU, K8, Wa and Birmingham I were included in serotype 1, $2, DS-1, HN-126, KUN and Birmingham II in serotype 2, YO, M, P, MO, Ito, Nemoto and Birmingham III in serotype 3 and St Thomas 4, Hochi and Hosokawa in serotype 4. However, at the same time, the antigenic complexity in HRV strains has been recognized since, in many cases, intratypic differences and intertypic relations have also been found. Thus, more information is needed on the antigenic properties of HRV. Furthermore, development of a simple and rapid method for determining serotype specificity of numerous HRV strains is required. Preparations of neutralizing monoclonal antibodies would be useful for these purposes.
So far, although some non-neutralizing monoclonal antibodies against HRV have been prepared (Gary et al., 1982 : Sonza et al., 1983 , no reports have been presented describing the production and characterization of neutralizing monoclonal antibodies against HRV. In this study, by modifying the procedure for preparation of purified HRV antigen and the screening assay of hybridoma culture fluids, we derived | 1 neutralizing monoclonal antibodies against HRV. Of these, seven antibodies had serotype specificity; one was specific for serotype 1 HRV, five for serotype 2 HRV, and one for serotype 3 HRV. Two antibodies reacted specifically to the homologous strain ($2), and the remaining two antibodies neutralized commonly the infectivities of all the HRV strains examined except either K8 or DS-1, although the strength of their reactivity to the individual virus strains varied to some extent. These commonly reactive antibodies were derived from fusions using spleen cells from mice immunized with KU (serotype 1) or YO (serotype 3) strain. Also, in the initial screening assay for anti-HRV neutralizing activity of hybridomas which were obtained in fusion experiments using the KU or YO strain as the immunizing antigen, cross-reactive hybridomas were found at relatively high frequency but many degenerated and could not be established. In contrast, none of more than 50 hybridomas that were positive for anti-S2 neutralizing activity at the initial screening, had the heterologous reactivity of serotype 1 or 3 HRV strains. In this connection, it is our experience that hyperimmunized rabbit antisera to serotype 1 or 3 HRV tended to cross-neutralize the heterologous serotype HRV strains and that hyperimmunized rabbit antisera to serotype 2 HRV hardly neutralized serotype 1 and 3 HRV strains, These findings might imply a weaker immunogenicity of the common reactive neutralizing antigen on serotype 2 HRV strains.
Studies on the viral polypeptides of cultivable simian and bovine rotaviruses performed extensively by several investigators showed that the results obtained differed among individual investigators, especially with the three or four high molecular weight viral polypeptides encoded by RNA segments 1, 2, 3 and 4. Arias et al. (1982) reported that the gene products of RNA segments 3 and 4 were trypsin-sensitive VP3 and non-structural polypeptide NCVP1, respectively. It has been reported by Dyall-Smith & Holmes (1981) that both segments 3 and 4 coded for inner capsid structural polypeptides (p91 and p84). McCrae & McCorquodale (1982) , in contrast, described that segments 3 and 4 produced inner capsid protein VP3 and outer capsid protein VP4, respectively. Further, the gene product of segment 4 was identified as VP3 in the outer shell of the virus by Ericson et al. (1982) . The reported discrepancies have been thoroughly reviewed by Estes et al. (1983) . In contrast to these, little is known to date concerning the viral polypeptides of HRV strains. In this study, the protein profiles of three cultivable HRV strains were compared with that of SA 11 virus. Overall, the polypeptide patterns of HRVs were similar to that of SA1 l virus although the 34K to 38K protein (VP7) of the HRV strains could not be labelled well under the conditions used in the present study. In our polyacrylamide gel results, VP4 could not be observed as described by Ericson et al. (1982) . Detailed examinations of the polypeptides of HRV strains, including gene-coding assignments, would be necessary to elucidate these points.
In immunoprecipitation analysis, four serotype-specific and two commonly reactive neutralizing antibodies precipitated the third highest molecular weight polypeptide (82K) which can be designated as VP3 according to the nomenclature of the rotavirus proteins by Estes et al. (1983) . Furthermore, the antigens bound exclusively to DS particles. These results indicate that VP3 (82K protein) on the outer capsid carries serotype-specific and commonly reactive neutralizing antigens. However, this result seems incompatible with previous findings reported by other investigators. Kalica et al. (1981) and Greenberg et al. (1983b) , in the analysis of reassortant viruses, indicated that neutralizing and serotype-specific antigen is associated with RNA segment 8 or 9, which codes for VP7 (34K to 38K glycoprotein). Furthermore, Greenberg et al. (1983c) characterized numerous neutralizing monoclonal antibodies against a simian rotavirus strain and described that monoclonal antibodies to 82K protein (VP3) had low, if any, neutralizing activity and strain-specific reactivity, whereas monoclonal antibodies to 34K glycoprotein (VP7) had strong neutralizing activity and serotype 3-specific reactivity. To confirm whether VP3 intrinsically carries a serotype-specific antigenic site, it may be necessary to prepare and characterize more hybridomas against several HRV strains.
Five monoclonal antibodies failed to precipitate any of the viral polypeptides. Even when rabbit antiserum to mouse IgG was employed as the second antibody, or even when concentrated (20-fold) culture fluids or ascitic fluids of the antibodies were used, these antibodies did not react with any of viral proteins. The low affinity of the antibodies or conformational changes of the polypeptides occurring in the viral lysates might explain the failure in immunoprecipitation of these antibodies.
